Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001403
Filing Date
2015-08-05
Accepted
2015-08-05 13:34:22
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20150630x10q.htm 10-Q 1374539
2 EX-31.1 tlog-20150630ex311d4b3ea.htm EX-31.1 20133
3 EX-31.2 tlog-20150630ex312c4a773.htm EX-31.2 19818
4 EX-32.1 tlog-20150630ex321a0eb17.htm EX-32.1 9644
5 EX-32.2 tlog-20150630ex322a92138.htm EX-32.2 9202
  Complete submission text file 0001558370-15-001403.txt   6421125

Data Files

Seq Description Document Type Size
6 EX-101.INS tlog-20150630.xml EX-101.INS 1629403
7 EX-101.SCH tlog-20150630.xsd EX-101.SCH 34498
8 EX-101.CAL tlog-20150630_cal.xml EX-101.CAL 48387
9 EX-101.DEF tlog-20150630_def.xml EX-101.DEF 148961
10 EX-101.LAB tlog-20150630_lab.xml EX-101.LAB 407890
11 EX-101.PRE tlog-20150630_pre.xml EX-101.PRE 271686
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 151028380
SIC: 2834 Pharmaceutical Preparations